Skip to main content

Advertisement

Log in

Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Anorexia is a problem of paramount importance in patients with advanced liver failure. Ghrelin has important actions on feeding and weight homeostasis. Concentrations of ghrelin are controversial in liver cirrhosis. Our aim was to study fasting ghrelin and their response to an oral glucose tolerance test (OGTT) in liver failure patients and normal subjects. Methods We included 16 patients with severe liver failure prior to liver transplantation. As a control group we included 10 age- and BMI-matched healthy subjects. After an overnight fast, 75 g of oral glucose were administered; glucose, insulin, and ghrelin were obtained at baseline and at times 30, 60, 90, and 120 min, respectively. Results Fasting ghrelin (median and range) were statistically significantly lower for patients compared to the controls, 527 (377–971) pg/ml vs. 643 (523–2163) pg/ml, P = 0.045, for patients and controls, respectively. The area under the curve for total ghrelin post-OGTT were lower in end-stage liver failure patients than in the control group, 58815 (44730–87420) pg/ml min vs. 76560 (56160–206385) pg/ml min, for patients and controls, respectively, P = 0.027. Conclusions Ghrelin levels are significantly decreased both fasting and post-OGTT in patients with liver failure candidates for transplantation. Decreased ghrelin levels could contribute to anorexia in patients with cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. O. Selberg, J. Böttcher, G. Tusch, R. Pichlmayr, E. Henkel, M.J. Muller, Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25, 652–657 (1997)

    Article  CAS  PubMed  Google Scholar 

  2. C. Matos, M.K. Porayko, N. Francisco-Ziller, S. DiCecco, Nutrition and chronic liver disease. J. Clin. Gastroenterol. 35, 391–397 (2002)

    Article  CAS  PubMed  Google Scholar 

  3. H.I.M. Davidson, R. Richardson, D. Sutherland, O.J. Garden, Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. Hepatology 29, 1380–1386 (1999)

    Article  CAS  PubMed  Google Scholar 

  4. G. Marchesini, G. Bianchi, P. Lucidi, N. Villanova, M. Zoli, P. De Feo, Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J. Clin. Endocrinol. Metab. 89, 2136–2141 (2004)

    Article  CAS  PubMed  Google Scholar 

  5. J. Ockenga, S.C. Bischoff, H.L. Tillmann, K. Rifai, A. Widjaja, K.H. Böker, M.P. Manns, G. Brabant, Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 119, 1656–1662 (2001)

    Article  Google Scholar 

  6. A.M. Madden, M.Y. Morgan, Resting energy expenditure should be measured in patients with cirrhosis, not predicted. Hepatology 30, 655–664 (1999)

    Article  CAS  PubMed  Google Scholar 

  7. A. Laviano, C. Cangiano, I. Preziosa, O. Riggio, L. Conversano, A. Cascino, S. Ariemma, F. Rossi Fanelli, Plasma tryptophan levels and anorexia in liver cirrhosis. Int. J. Eat. Disord. 21, 181–186 (1997)

    Article  CAS  PubMed  Google Scholar 

  8. H.U. Lautz, O. Selberg, J. Korber, M. Burger, M.J. Muller, Forms of malnutrition in patients with liver cirrhosis. Clin. Invest. 70, 178–186 (1992)

    Article  Google Scholar 

  9. M. Merli, O. Riggio, L. Dally, Does malnutrition affect survival in cirrhosis? Policentrica Italiana Nutrizione Cirrosi (PINC). Hepatology 23, 1041–1046 (1996)

    Article  CAS  PubMed  Google Scholar 

  10. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 402, 656–658 (1999)

    Article  CAS  PubMed  Google Scholar 

  11. F. Cordido, A. Peñalva, C. Dieguez, F. Casanueva, Massive growth hormone (GH) discharge in obese subjects after the combined administration of Growth Hormone releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J. Clin. Endocrinol. Metab. 76, 819–823 (1993)

    Article  CAS  PubMed  Google Scholar 

  12. P. Alvarez, L. Isidro, J. Garcia-Buela, J. Leal-Cerro, F. Broglio, F. Tassone, E. Ghigo, C. Dieguez, F.F. Casanueva, F. Cordido, Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin. Endocrinol. 61, 250–255 (2004)

    Article  Google Scholar 

  13. A.J. van der Lely, M. Tschop, M.L. Heiman, E. Ghigo, Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25, 426–457 (2004)

    Article  PubMed  Google Scholar 

  14. M. Tschop, D.L. Smiley, M.L. Heiman, Ghrelin induces adiposity in rodents. Nature 407, 908–909 (2000)

    Article  CAS  PubMed  Google Scholar 

  15. M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, S. Matsukura, A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001)

    Article  CAS  PubMed  Google Scholar 

  16. Y. Shuto, T. Shibasaki, A. Otagiri, H. Kuriyama, H. Ohata, H. Tamura, J. Kamegai, H. Sugihara, S. Oikawa, I. Wakabayashi, Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding and adiposity. J. Clin. Invest. 109, 1429–1436 (2002)

    CAS  PubMed  Google Scholar 

  17. A.M. Wren, L.J. Seal, M.A. Cohen, A.E. Brynes, G.S. Frost, K.G. Murphy, Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992–5998 (2001)

    Article  CAS  PubMed  Google Scholar 

  18. D.E. Cummings, K. Clement, J.Q. Purnell, C. Vaisse, K.E. Foster, R.S. Frayo, M.W. Schwartz, A. Basdevant, D.S. Weigle, Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat. Med. 8, 643–644 (2002)

    Article  CAS  PubMed  Google Scholar 

  19. D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, J.Q. Purnell, Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623–1630 (2002)

    Article  PubMed  Google Scholar 

  20. M. Tschop, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L. Heiman, Circulating ghrelin are decreased in human obesity. Diabetes 50, 707–709 (2001)

    Article  CAS  PubMed  Google Scholar 

  21. A.M. Haqq, I.S. O′Farooqi, S. Rahilly, D.D. Stadler, R.G. Rosenfeld, K.L. Prat, S.H. LaFranchi, J.Q. Purnell, Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88, 174–178 (2003)

    Article  CAS  PubMed  Google Scholar 

  22. G. Muccioli, M. Tschop, M. Papotti, R. Deghenghi, M. Heiman, E. Ghigo, Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 440, 235–254 (2002)

    Article  CAS  PubMed  Google Scholar 

  23. B. Otto, U. Cuntz, E. Fruehauf, R. Wawarta, C. Folwaczny, R.L. Riepl, M.L. Heiman, P. Lehnert, M. Fichter, M. Tschöp, Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145, 669–673 (2001)

    Article  CAS  PubMed  Google Scholar 

  24. O. Ukkola, Ghrelin and insulin metabolism. Eur. J. Clin. Invest. 33, 183–185 (2003)

    Article  CAS  PubMed  Google Scholar 

  25. A. Asakawa, A. Inui, T. Kaga, G. Katsuura, M. Fujimiya, M.A. Fujino, M. Kasuga, Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52, 947–952 (2003)

    Article  CAS  PubMed  Google Scholar 

  26. T. McLaughlin, F. Abbasi, C. Lamendola, R.S. Frayo, D.E. Cummings, Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J. Clin. Endocrinol. Metab. 89, 1630–1635 (2004)

    Article  CAS  PubMed  Google Scholar 

  27. T. Shiiya, M. Nakazato, M. Mizuta, Y. Date, M.S. Mondal, M. Tanaka, S. Nozoe, H. Hosoda, K. Kangawa, S. Matsukura, Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87, 240–244 (2002)

    Article  CAS  PubMed  Google Scholar 

  28. D.E. Cummings, J.Q. Purnell, R.S. Frayo, K. Schmidova, B.E. Wisse, D.S. Weigle, A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719 (2001)

    Article  CAS  PubMed  Google Scholar 

  29. M. Kojima, K. Kangawa, Ghrelin: structure and function. Physiol. Rev. 85, 495–522 (2005)

    Article  CAS  PubMed  Google Scholar 

  30. M. Hotta, R. Ohwada, H. Katakami, T. Shibasaki, N. Hizuka, K. Takano, Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J. Clin. Endocrinol. Metab. 89, 571–5707 (2004)

    Article  Google Scholar 

  31. E. Kalaitzakis, I. Bosaeus, L. Ohman, E. Björnsson, Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am. J. Clin. Nutr. 85, 808–815 (2007)

    CAS  PubMed  Google Scholar 

  32. H. Ataseven, I.H. Bahcecioglu, N. Kuzu, M. Yalniz, S. Celebi, A. Erensoy, B. Ustundag, The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006, 78380–78385 (2006)

    Article  PubMed  Google Scholar 

  33. H. Takahashi, A. Kato, K. Onodera, K. Suzuki, Fasting plasma ghrelin levels reflect malnutrition state in patients with liver cirrhosis. Hepatol. Res. 34, 117–123 (2006)

    Article  CAS  PubMed  Google Scholar 

  34. M. Breidert, T.F. Zimmermann, R. Schneider, G. Ehninger, G. Brabant, Ghrelin/Leptin-imbalance in patients with primary biliary cirrhosis. Exp. Clin. Endocrinol. Diabetes 112, 123–126 (2004)

    Article  CAS  PubMed  Google Scholar 

  35. F. Tacke, G. Brabant, E. Kruck, R. Horn, P. Schöffski, H. Hecker, M.P. Manns, C. Trautwein, Ghrelin in chronic liver disease. J. Hepatol. 38, 447–454 (2003)

    Article  CAS  PubMed  Google Scholar 

  36. M. Granado, A.I. Martín, M. López-Menduiña, A. López-Calderón, M.A. Villanúa, GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am. J. Physiol. Endocrinol. Metab. 294, E131–E141 (2008)

    Article  CAS  PubMed  Google Scholar 

  37. S.O. Işeri, G. Sener, B. Saglam, F. Ercan, N. Gedik, B.C. Yeğen, Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul. Pept. 146, 73–79 (2008)

    Article  PubMed  Google Scholar 

  38. O. Kasımay, S.O. Işeri, A. Barlas, D. Bangir, C. Yeğen, S. Arbak, B.C. Yeğen, Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol. Res. 36, 11–19 (2006)

    Article  PubMed  Google Scholar 

  39. H. Hosoda, M. Kojima, T. Mizushima, S. Shimizu, K. Kangawa, Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J. Biol. Chem. 278, 64–70 (2003)

    Article  CAS  PubMed  Google Scholar 

  40. X. Zhu, Y. Cao, K. Voodg, D.F. Steiner, On the processing of proghrelin to ghrelin. J. Biol. Chem. 281, 38867–38870 (2006)

    Article  CAS  PubMed  Google Scholar 

  41. M.A. Bednarek, S.D. Feighner, S.S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren, A.D. Howard, L.H. Van Der Ploeg, J.V. Heck, Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43, 4370–4376 (2000)

    Article  CAS  PubMed  Google Scholar 

  42. P. Cassoni, M. Papotti, C. Ghe, F. Catapano, A. Sapino, A. Graziani, R. Deghenghi, T. Reissmann, E. Ghigo, G. Muccioli, Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86, 1738–1745 (2001)

    Article  CAS  PubMed  Google Scholar 

  43. I. Bedendi, G. Alloatti, A. Marcantoni, D. Malan, F. Catapano, C. Ghe, R. Deghenghi, E. Ghigo, G. Muccioli, Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur. J. Pharmacol. 476, 87–95 (2003)

    Article  CAS  PubMed  Google Scholar 

  44. N.M. Thompson, D.A. Gill, R. Davies, N. Loveridge, P.A. Houston, I.C. Robinson, T. Wells, Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145, 234–242 (2004)

    Article  CAS  PubMed  Google Scholar 

  45. K. Toshinai, H. Yamaguchi, Y.X. Sun, R.G. Smith, A. Yamanaka, T. Sakurai, Y. Date, M.S. Mondal, T. Shimbara, T. Kawagoe, N. Murakami, M. Miyazato, K. Kangawa, M. Nakazato, Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147, 2306–2314 (2006)

    Article  CAS  PubMed  Google Scholar 

  46. C. Gauna, P.J. Delhanty, M.O. van Aken, J.A. Janssen, A.P. Themmen, L.J. Hofland, M. Culler, F. Broglio, E. Ghigo, A.J. van der Lely, Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol. Cell. Endocrinol. 251, 103–111 (2006)

    Article  CAS  PubMed  Google Scholar 

  47. C. Gauna, F.M. Meyler, J.A. Janssen, P.J.D. Delhanty, T. Abribat, P. van Koetsveld, L.J. Hofland, F. Broglio, E. Ghigo, A.J. van der Lely, Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J. Clin. Endocrinol. Metab. 89, 5035–5042 (2004)

    Article  CAS  PubMed  Google Scholar 

  48. M. Tschöp, R. Wawarta, R.L. Riepl, S. Friedrich, M. Bidlingmaier, R. Landgraf, C. Folwaczny, Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24, RC19–RC21 (2001)

    PubMed  Google Scholar 

  49. K.E. Foster-Schubert, J. Overduin, C.E. Prudom, J. Liu, H.S. Callahan, B.D. Gaylinn, M.O. Thorner, D.E. Cummings, Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab. 93, 1971–1979 (2008)

    Article  CAS  PubMed  Google Scholar 

  50. J. Liu, C.E. Prudom, R. Nass, S.S. Pezzoli, M.C. Oliveri, M.L. Johnson, P. Veldhuis, D.A. Gordon, A.D. Howard, D.R. Witcher, H.M. Geysen, B.D. Gaylinn, M.O. Thorner, Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J. Clin. Endocrinol. Metab. 93, 1980–1987 (2008)

    Article  CAS  PubMed  Google Scholar 

  51. G. Marchesini, U. Pagotto, E. Bugianesi, R. De Iasio, R. Manini, E. Vanni, R. Pasquali, N. Melchionda, M. Rizzetto, Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J. Clin. Endocrinol. Metab. 88, 5674–5679 (2003)

    Article  CAS  PubMed  Google Scholar 

  52. G. Murdolo, P. Lucidi, C. Di Loreto, N. Parlanti, A. De Cicco, C. Fatone, C.G. Fanelli, G.B. Bolli, F. Santeusanio, P. De Feo, Insulin is required for prandial ghrelin suppression in humans. Diabetes 52, 2923–2927 (2003)

    Article  CAS  PubMed  Google Scholar 

  53. D.E. Flanagan, M.L. Evans, T.P. Monsod, F. Rife, R.A. Heptulla, W.V. Tamborlane, R.S. Sherwin, The influence of insulin on circulating ghrelin. Am. J. Physiol. Endocrinol. Metab. 284, E313–E316 (2003)

    CAS  PubMed  Google Scholar 

  54. W.A.M. Blom, A. Stafleu, C. de Graaf, F.J. Kok, G. Schaafsma, H.F. Hendriks, Ghrelin response to carbohydrate-enriched breakfast is related to insulin. Am. J. Clin. Nutr. 81, 367–375 (2005)

    CAS  PubMed  Google Scholar 

  55. A. Caixas, C. Bashore, W. Nash, X. Pi-Sunyer, B. Laferrere, Insulin, unlike food intake, does not suppress ghrelin in human subjects. J. Clin. Endocrinol. Metab. 87, 1902–1905 (2002)

    Article  CAS  PubMed  Google Scholar 

  56. G. Schaller, A. Schmidt, J. Pleiner, W. Woloszczuk, M. Woltz, A. Luger, Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 5, 16–20 (2003)

    Article  Google Scholar 

  57. R. Nass, L.S. Farhy, J. Liu, C.E. Prudom, M.L. Johnson, P. Veldhuis, S.S. Pezzoli, M.C. Oliveri, B.D. Gaylinn, H.M. Geysen, M.O. Thorner, Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J. Clin. Endocrinol. Metab. 93, 1988–1994 (2008)

    Article  CAS  PubMed  Google Scholar 

  58. F.M. Van der Toorn, J.A. Janssen, W.W. de Herder, F. Broglio, E. Ghigo, A.J. van der Lely, Central ghrelin production does not substantially contribute to systemic ghrelin concentration: a study inn two subjects with active acromegaly. Eur. J. Endocrinol. 147, 195–199 (2002)

    Article  PubMed  Google Scholar 

  59. A.L. Barkan, E.V. Dimaraki, S.K. Jessup, K.V. Symons, M. Ermolenko, C.A. Jaffe, Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metab. 88, 2180–2184 (2003)

    Article  CAS  PubMed  Google Scholar 

  60. Z. Jarkovska, M. Rosicka, J. Marek, V. Hana, V. Weiss, V. Justova, Z. Lacinová, M. Haluzík, M. Krsek, Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Physiol. Res. 55, 175–181 (2006)

    CAS  PubMed  Google Scholar 

  61. M.L. Isidro, R. Nemiña, J. Garcia-Buela, S. Sangiao-Alvarellos, F. Cordido, Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients. Neuro Endocrinol. Lett. 28, 596–603 (2007)

    CAS  PubMed  Google Scholar 

  62. V. Cappiello, C. Ronchi, P.S. Mospurgo, P. Epaminonda, P. Beck-Peccoz, A. Spada, Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur. J. Endocrinol. 147, 189–194 (2002)

    Article  CAS  PubMed  Google Scholar 

  63. P.U. Freda, C.M. Reyes, I.M. Conwell, R.E. Sundeen, S.L. Wardlaw, Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J. Clin. Endocrinol. Metab. 88, 2037–2044 (2003)

    Article  CAS  PubMed  Google Scholar 

  64. J. Kozakowski, M. Rabijewski, W. Zgliczynski, Decreased in serum ghrelin levels in patients with acromegaly normalize after successful surgical treatment. Endokrynol. Pol. 56, 862–870 (2005)

    PubMed  Google Scholar 

  65. E.T. Vestergaard, R. Dall, K.H. Lange, M. Kjaer, J.S. Christiansen, J.O. Jorgensen, The ghrelin response to exercise before and after growth hormone administration. J. Clin. Endocrinol. Metab. 92, 297–303 (2007)

    Article  CAS  PubMed  Google Scholar 

  66. H.J. Kim, L. Sangyeoup, T.W. Kim, H.H. Kim, T.Y. Jeon, Y.S. Yoon, S.W. Oh, H. Kwak, J.G. Lee, Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin. Endocrinol. 68, 416–422 (2008)

    CAS  Google Scholar 

  67. M. Perez-Fontán, F. Cordido, A. Rodriguez-Carmona, J. Peteiro, R. Garcia-Naveiro, J. Garcia-Buela, Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal diálysis. Nephrol. Dial. Transplant. 19, 2095–2100 (2004)

    Article  PubMed  Google Scholar 

  68. M. Perez-Fontán, F. Cordido, A. Rodriguez-Carmona, R. Garcia-Naveiro, M.L. Isidro, P. Villaverde, J. Garcia-Buela, Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int. 2005(68), 2877–2885 (2005)

    Article  Google Scholar 

  69. M. Pérez-Fontán, F. Cordido, A. Rodríguez-Carmona, M. Penín, H. Díaz-Cambre, A. López-Muñiz, S. Sangiao-Alvarellos, J. García-Buela, Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure. Nephrol. Dial. Transplant. 23, 3696–3703 (2008)

    Article  PubMed  Google Scholar 

  70. D.R. Matthews, J.P. Hosker, A.S. Rudenski, D.B. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetología 28, 412–419 (1985)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Rosa Nemiña, Ramón Pensado, Iria Brandón, and Sonia Pertega for his technical assistance. Supported in part by: FIS del Instituto de Salud Carlos III PI051024, PI070413 and Red de Grupos RGTO (G03/028, PI050983) and Xunta de Galicia PS07/12, PGIDT05PXIC91605PN, INCITE08ENA916110ES and Redes 2006/27, Spain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernando Cordido.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diz-Lois, M.T., Garcia-Buela, J., Suarez, F. et al. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. Endocr 35, 467–476 (2009). https://doi.org/10.1007/s12020-009-9170-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-009-9170-6

Keywords

Navigation